Product NewsNaurex Announces Initiation of Phase I Trial for Second-Generation NOVEL ANTIDEPRESSANT AGENT NRX-1074
Product NewsGenticel Secures EUR 18.2 million (USD 23.7 million) in Capital Funding to Develop Vaccines for Patients Infected with HPV
Product NewsAddex Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant
Product NewsMersana Therapeutics Presents Positive Preclinical Data on Next-Generation Antibody-Drug Conjugate Technology at AACR 2013